Marapharm Ventures Inc. is pleased to announce that its shares are listed on the Canadian Securities Exchange (CSE), which this week reinforced its support for firms with links to the US cannabis market in comments to a Canadian national newspaper.
On October 18, 2017 the Globe and Mail reported that while the Toronto Stock Exchange (TMX) threatened to kick companies with ties to US cannabis off of its exchanges, the CSE continues to welcome firms with links to the U.S. cannabis market. The TMX is not allowing cannabis companies that could violate U.S. federal law to list on the Toronto Stock Exchange or TSX Venture Exchange (TSX-V), and has initiated a review of existing issuers to determine if any should be delisted.
Issuers removed from the TSX or TSX-V may be able to find a new home on the CSE. â€œWe obviously have a starkly different opinion when it comes to this space,â€ said Richard Carleton, chief executive officer of CNSX Markets, which runs the CSE. â€œThis is clearly one of the biggest growth spaces in the public capital markets. We are ready and willing to work with these companies.â€
Speaking in response to the threats by TSX, Marapharm CEO Linda Sampson said, â€œThe CSE is an exchange for entrepreneurs. Marapharm is proud to have selected listing on the CSE more than 2 years ago because we knew that it was the safest and strongest place to be for our shareholders. This recent disappointing move by the TMX reinforces our decision.â€
Click here to read the original article.